M
Matinas BioPharma Holdings D
D
MTNB
2.33700
USD
0.69
(42.07%)
مغلق
حجم التداول
525,970
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
11,888,284
الأخبار المقالات
العنوان: Matinas Biopharma Holdings Inc
القطاع: Healthcare
الصناعة: Biotechnology
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.